Risk and influencing factors of secondary hypertension, hyperglycemia and hyperlipidemia after cancer treatment.
Principal Investigator
Name
Qian Zhu
Degrees
Ph.D
Institution
Panzhihua Central Hospital
Position Title
Dr.
Email
About this CDAS Project
Study
PLCO
(Learn more about this study)
Project ID
PLCO-1621
Initial CDAS Request Approval
Jul 22, 2024
Title
Risk and influencing factors of secondary hypertension, hyperglycemia and hyperlipidemia after cancer treatment.
Summary
Cancer patients and survivors have an increased burden of morbidity and mortality from chronic diseases, especially hypertension, compared to the general population. Due to different cancers, different use of antitumor drugs, and population heterogeneity, there is a lack of large sample epidemiological data on the occurrence and influencing factors of hypertension and diabetes after cancer treatment.
Aims
We aimed to assess the risk and contributing factors for secondary hypertension, hyperglycemia and hyperlipidemia following cancer treatment.
Collaborators
Xianzhi Li, Panzhihua Central Hospital, Panzhihua, China.
Yunyun Tian, Panzhihua Central Hospital, Panzhihua, China.
Shunjin Liu ,Panzhihua Central Hospital, Panzhihua, China.
Li Yin,Panzhihua Central Hospital, Panzhihua, China.